Nasal vaccination with attenuated Salmonella typhimurium strains expressing the Hepatitis B nucleocapsid: Dose response analysis

Vaccine

Volumn 19, Issue 20-22, 2001, Pages 2854-2861

  Nardelli Haefliger, Denise ^a   Benyacoub, Jalil ^a   Lemoine, Robert ^a   Hopkins Donaldson, Sally ^b   Potts, Alexandra ^a   Hartman, Françoise ^a   Kraehenbuhl, Jean Pierre ^b   De Grandi, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Antibody response; Nasal vaccination; Salmonella

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVE VACCINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BRONCHOPNEUMONIA; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; HEPATITIS B; HEPATITIS B VIRUS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; VACCINATION; VIRUS NUCLEOCAPSID; VIRUS STRAIN;

ADMINISTRATION, INTRANASAL; ANIMALS; CAPSID; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; LUNG; MICE; MICE, INBRED BALB C; SALMONELLA TYPHIMURIUM; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0035815552     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00009-3     Document Type: Article

References (31)

1. Attenuated Salmonella strains as live vectors for the expression of foreign antigens
2. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors
3. Prospects for oral vaccination using recombinant bacteria expressing viral epitopes
4. Recombinant Salmonella vectors in vaccine development
5. Nonrecombinant and recombinant avirulent Salmonella vacines
6. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization
7. Expression and immunogenicity of pertussis toxin s1 subunit-tetanus toxin fragment c fusions in Salmonella typhi vaccine strain CVD 908
8. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens
9. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice
10. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin a2 and b subunits
11. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits
12. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A
13. Nasal-associated lymphoid tissue, a site for vaccination and pathogen entry
14. Construction and characterization of a Salmonella enterica serovar Typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter
15. The nature of the attenuation of S. typhimurium strains expressig human papillomavirus type 16 virus like particles determines the specific antibody responses in nasally immunized mice
16. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination
17. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages
18. Isolation of orally attenuated Salmonella typhimurium following TnphoA mutagenesis
19. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions
20. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors
21. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge
22. Avirulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination
23. The hepatitis B virus core and e antigens elicit different Th cell subsets: Antigen structure can affect Th cell phenotype
24. Role of b cells in antigen presentation of the hepatitis b core
25. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp(63)) preferentially induces T helper 1 cells and protective immunity against leishmaniasis
26. Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza A nucleoprotein
27. Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-gamma-dominant versus an IL-4-dominant immune response
28. Regulation of mucosal and systemic antibody responses by t helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant salmonella
29. A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium